<SEC-DOCUMENT>0000950123-10-112779.txt : 20110307
<SEC-HEADER>0000950123-10-112779.hdr.sgml : 20110307
<ACCEPTANCE-DATETIME>20101210152018
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950123-10-112779
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20101210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MILESTONE SCIENTIFIC INC.
		CENTRAL INDEX KEY:			0000855683
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				133545623
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		45 KNIGHTSBRIDGE ROAD
		CITY:			PISCATAWAY
		STATE:			NJ
		ZIP:			08854
		BUSINESS PHONE:		(973) 535-2717

	MAIL ADDRESS:	
		STREET 1:		45 KNIGHTSBRIDGE ROAD
		CITY:			PISCATAWAY
		STATE:			NJ
		ZIP:			08854

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MILESTONE SCIENTIFIC INC/NJ
		DATE OF NAME CHANGE:	19970409

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	U S OPPORTUNITY SEARCH INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
<TITLE>Correspondence</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<P align="left" style="font-size: 10pt; margin-left: 60%">Milestone Scientific Inc.<BR>
220 South Orange Avenue<BR>
Livingston, New Jersey 07039<BR>
(973)&nbsp;535-2717


<P align="left" style="font-size: 10pt">December&nbsp;10, 2010


<P align="left" style="font-size: 10pt">Securities and Exchange Commission<BR>
Division of Corporate Finance<BR>
100 F Street NE<BR>
Washington, D.C. 20549

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="82%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD valign="top">Attention:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mr.&nbsp;Kevin Kuhar<BR>
    Staff Accountant</TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD colspan="4">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD valign="top"><B>Re:</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Milestone Scientific Inc. (the &#147;Company&#148;)<BR>
    Form&nbsp;10-K for the Fiscal Year ended December&nbsp;31, 2009<BR>
    Filed March&nbsp;10, 2010 (the &#147;Annual Report&#148;)<BR>
    Definitive Proxy Statement filed April&nbsp;14, 2010<BR>
    File No.&nbsp;001-14053 (the &#147;Proxy Statement&#148;)</B></TD>
</TR>
</TABLE>
</DIV>


<P align="left" style="font-size: 10pt">Dear Mr.&nbsp;Kuhar:


<P align="left" style="font-size: 10pt">This letter is in response to the Staff&#146;s comment letter dated November&nbsp;30, 2010 regarding the Annual Report and the
Proxy Statement. Our responses are keyed to the number of each comment in your letter. For the convenience of the
Staff&#146;s review, we have set forth the comment contained in the letter above each respective response.


<P align="left" style="font-size: 10pt">Your comment:


<P align="left" style="font-size: 10pt"><U><B>Form&nbsp;10-K for the Fiscal Year Ended December&nbsp;31, 2010</B></U>


<P align="left" style="font-size: 10pt"><U><B>Item&nbsp;9A. Controls and Procedures, page 22</B></U>


<P align="left" style="font-size: 10pt"><U><B>Management&#146;s Annual Report on Internal Control Over Financial Reporting, page 23</B></U>


<P align="left" style="font-size: 10pt">1.&nbsp;<B>We note your disclosure that there &#147;have been no </B><U><B>significant </B></U><B>changes in the Company&#146;s internal controls over
financial reporting&#148; Item&nbsp;308 (T)(b) of Regulation&nbsp;S-K requires you to disclose </B><U><B>any change</B></U><B> in your internal
control over financial reporting that occurred during the your last fiscal quarter that has materially affected, or is
reasonably likely to materially affect, your internal control over financial reporting. Please confirm for us in your
response whether there were any changes required to be disclosed by Item&nbsp;308(T)(b) of Regulation&nbsp;S-K for the fiscal
quarter ended December&nbsp;31, 2009. In addition, please also revise future filings, if true, to clearly disclose that in connection with your evaluation, </B><U><B>no changes</B></U><B> in internal control over
financial reporting were identified that occurred during the quarter ended December&nbsp;31, 2009 that has materially
affected, or is reasonably likely to materially affect, your internal control over financial reporting.</B>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<P align="left" style="font-size: 10pt"><B>Our response:</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">There were no changes in the Company&#146;s internal controls over financial reporting as required by Item&nbsp;308(T)(b) of
Regulation&nbsp;S-K for the final quarter ended December&nbsp;31, 2009. Also, we will revise future filings to clearly disclose
no changes or any changes that occurred in connection with an evaluation of internal control over financial reporting
that occurred during the fourth quarter, as appropriate.


<P align="left" style="font-size: 10pt"><U><B>Key Personnel, page 24</B></U>


<P align="left" style="font-size: 10pt">2.&nbsp;<B>Please confirm that in future filings, you will briefly discuss the specific experience, qualifications, attributes
or skills that led to the conclusion that each director should serve as a director. For example, we note that you have
not provided such information for Mr.&nbsp;Fuller. See Item&nbsp;401 (c)&nbsp;of Regulation&nbsp;S-K.</B>


<P align="left" style="font-size: 10pt"><B>Our response:</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">The Company will, in future filings, discuss the specific experience, qualifications, attributes or skills that
lead to a conclusion that each director should serve as a director. With the exception of Mr.&nbsp;Fuller, such disclosure
was included in the biographical description of each director included in the Proxy Statement.


<P align="left" style="font-size: 10pt"><U><B>Item&nbsp;12. Security Ownership of Certain Beneficial Owners &#151; page 29</B></U>


<P align="left" style="font-size: 10pt"><B>3.&nbsp;Please tell us why you did not include Joe W. Martin in the table. Please see </B><B>Item 403(b)</B><B> of Regulation&nbsp;S-K.</B>


<P align="left" style="font-size: 10pt"><B>Our response:</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">As of March&nbsp;11, 2010, &#147;the most recent practicable date&#148; used for the purposes of determining beneficial ownership
of the Company&#146;s Named Executive Officers, Directors and five percent shareholders set forth in the table included in
the Annual Report, almost one year had elapsed since Joe W. Martin resigned from all of his positions with the Company
on March&nbsp;27, 2009. Upon his resignation, with the exception of an opposite way transaction subject to Section 16(b) of
the Securities Exchange Act of 1934 (the &#147;Act&#148;), Mr.&nbsp;Martin was no longer required to comply with the reporting
requirements of Section&nbsp;16 of the Act. The last Form&nbsp;4 filed by Mr.&nbsp;Martin was dated February&nbsp;27, 2009. As such, the
Company decided not to include disclosure of Mr.&nbsp;Martin&#146;s beneficial ownership of Company shares on the table because
it did not have reliable information as to the number of shares he beneficially owned as of the most recent practicable
date used in the Annual Report and was concerned about the disclosure of inaccurate information from a liability standpoint as well as the potential for it to mislead and confuse shareholders and investors alike.

<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt; display: none">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<P align="left" style="font-size: 10pt"><U><B>Item&nbsp;13. Certain Relationships and Related Transactions ...page 31</B></U>


<P align="left" style="font-size: 10pt"><B>4.&nbsp;Please identify to us the shareholder discussed in this section and describe how they are a related party pursuant
to </B><B>Item 404(a)</B><B> of Regulation&nbsp;S-K. Please also tell us the largest aggregated amount of principal outstanding during the
period for which disclosure is provided, the amount thereof outstanding at the end of the fiscal year, the amount of
principal paid during the periods for which disclosure is provided as required by Instruction 4 to </B><B>Item 404(a)</B><B> of
Regulation&nbsp;S-K and confirm to us that you will provide such disclosure in future filings. Also, please tell us why you
have not filed the agreements related to your relationship with this shareholder as exhibits as required by Item&nbsp;601 of
Regulation&nbsp;S-K.</B>


<P align="left" style="font-size: 10pt">Our response:


<P align="left" style="font-size: 10pt; text-indent: 4%">(a)&nbsp;The shareholder discussed in this note is K. Tucker Andersen and he is a related party pursuant to Item 404(a)
of Regulation&nbsp;S-K based on his ownership of 18.16% of the Company&#146;s outstanding common stock. The largest amount of
outstanding loan principal was $1.75&nbsp;million of which $450,000 remained outstanding as of December&nbsp;31, 2009. The
outstanding principal as of December&nbsp;31, 2008 was $1.75&nbsp;million. Interest expensed for the years ended December&nbsp;31, 2009
and 2008 were $154,027 and $116,374, respectively. Debt amortization related to the debt was $53,300 and $27,446 for
the years ended December&nbsp;31, 2009 and 2008, respectively. In December&nbsp;2009, $1.3 Million of the Line of Credit was
converted to 882,785 shares of the Company&#146;s common stock at a price of $1.58 per share. Further, the Company will
provide such disclosure in future filings.


<P align="left" style="font-size: 10pt; text-indent: 4%">(b)&nbsp;The Company will include copies of the relevant material loan documents as exhibits to its Annual Report on
Form 10-K for the fiscal year ending December&nbsp;31, 2010.


<P align="left" style="font-size: 10pt"><U><B>Financial Statements, page F-1</B></U>


<P align="left" style="font-size: 10pt"><U><B>Note L-Income Taxes</B></U>


<P align="left" style="font-size: 10pt"><B>5.&nbsp;We see that during the fiscal years ended December&nbsp;31, 2009 and 2008, you received $777,609 and $675,903,
respectively, for the &#147;sale of tax credits under the New Jersey Technology Business Tax Certificate Transfer Program&#148;,
and that you recorded the sale of these tax credits as part of other income. Please describe for us in greater detail
these transactions. Specifically, please include the significant terms associated with the sale of these tax credits, a
description of the parties involved, your relationship with the counterparties, and the business reasons why you and
each of the counterparties would enter into such a transaction. Please quantify and describe for us how the amount of
other income was calculated including any cost basis associated with the credits and describe the US GAAP literature which supports the recognition of these sales of
tax credits as &#147;other income&#148; in your statement of operations.</B>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<P align="left" style="font-size: 10pt">Our response:


<P align="left" style="font-size: 10pt; text-indent: 4%">The Company, pursuant to the New Jersey Economic Development Authority, (NJEDA)&nbsp;Technology Business Tax
Certificate Transfer Program, www.njeda.com, provides for a qualifying company to sell its approved (approved by the
NJEDA,) tax losses to a third party as designated in the regulations. The Company chose to sell these tax losses to
increase its cash flow for the applicable periods. The income reported, is based on the applicable, approved net
operating losses for sale, multiplied by the applicable state income tax rate, less a discount to the purchase
(approximately 7%) and fees and expenses for the transaction (broker fee). The basis for the state net operating losses
is the tax affected balances, less the applicable reserve for realization. In the Company&#146;s case, the deferred tax
asset was fully reserved in prior years. The Company has never recognized tax provision and therefore the recognition
of the sale of net operating tax loss benefit for a third party, as a reversal of a provision tax provision did not
seem appropriate. It appears that the applicable GAAP does not contemplate the sale of net operating loss carry
forwards to third parties. Consequently, the Company chose to identify the sale of state net operating losses, to a
third party, as Other Income and to describe the transaction in the Note L-Income Taxes in its10K filings for December
31, 2009 and 2008. Although this Statement of Operations presentation is unusual, we believe that it better presents
the sale of these New Jersey Tax Loss Carry Forwards to an unrelated. third party.


<P align="left" style="font-size: 10pt"><U><B>Exhibit&nbsp;31</B></U>


<P align="left" style="font-size: 10pt"><B>6.&nbsp;We note that you replaced the word &#147;registrant&#148; with &#147;small business issurer&#148; in paragraph 4 of the certifications.
In future filings, please revise the certifications to present them in the exact form as set forth in Item
6</B><B>01(b)(31)(i)</B><B> of Regulation&nbsp;S-K with no modifications.</B>


<P align="left" style="font-size: 10pt">Our response:


<P align="left" style="font-size: 10pt; text-indent: 4%">The Company will revise the certifications to present them in exact form as set forth in Item&nbsp;601(b)(31)(i) of
Regulation&nbsp;S-K, with no modifications, in future filings.


<P align="left" style="font-size: 10pt"><U><B>Definitive Proxy Statement filed April&nbsp;14, 2010</B></U>


<P align="left" style="font-size: 10pt"><B>7.&nbsp;Please tell why you have not discussed the information required by </B><B>Item 407(h)</B><B> of Regulation&nbsp;S-K.</B>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="left" style="font-size: 10pt">Our response:

<P align="left" style="font-size: 10pt; text-indent: 4%">The following is the disclosure called for by Item 407(h) of Regulation&nbsp;S-K.&nbsp; We will include this disclosure
(updated to describe then current circumstances) in future filings which require Item 407(h) disclosure.


<P align="left" style="margin-left:4%; margin-right:4%; font-size: 10pt"><U>Board Leadership Structure</U>


<P align="left" style="margin-left:4%; margin-right:4%; font-size: 10pt; text-indent: 4%">The Board believes that the segregation of the roles of Board Chairman and the Chief Executive
Officer ensures better overall governance of the Company and provides meaningful checks and
balances regarding its overall performance. This structure allows our Chief Executive Officer to
focus on developing and implementing the Company&#146;s business plans and supervising the Company&#146;s
day-to-day business operations, and allows our Chairman to lead the Board in its oversight and
advisory roles. Because of the many responsibilities of the Board and the significant time and
effort required by each of the Chairman and the Chief Executive Officer to perform their respective
duties, the Company believes that having separate persons in these roles enhances the ability of
each to discharge those duties effectively and enhances the Company&#146;s prospects for success. The
Board also believes that having separate positions provides a clear delineation of responsibilities
for each position and fosters greater accountability of management. For the foregoing reasons, the
Board has determined that its leadership structure is appropriate and in the best interest of the
Shareholders.


<P align="left" style="margin-left:4%; margin-right:4%; font-size: 10pt"><U>The Board&#146;s Oversight of Risk Management</U>


<P align="left" style="margin-left:4%; margin-right:4%; font-size: 10pt; text-indent: 4%">The Board recognizes that companies face a variety of risks, including credit risk, liquidity
risk, strategic risk, and operational risk. The Board believes an effective risk management system
will (1)&nbsp;timely identify the material risks that we face, (2)&nbsp;communicate necessary information
with respect to material risks to senior executives and, as appropriate, to the Board or relevant
Board committee, (3)&nbsp;implement appropriate and responsive risk management strategies consistent
with the Company&#146;s risk profile, and (4)&nbsp;integrate risk management into Company decision-making.
The Board encourages and management promotes a corporate culture that incorporates risk management
into the Company&#146;s corporate strategy and day-to-day business operations. The Board also
continually works, with the input of our management and executive officers, to assess and analyze
the most likely areas of future risk for the Company.


<P align="left" style="font-size: 10pt; text-indent: 4%">In connection with our responses to the Staff comments set forth above, we acknowledge to you that (i)&nbsp;the Company
is responsible for the adequacy and accuracy of the disclosure in its filings under the Securities Exchange Act, (ii)
Staff comments or changes to disclosure in response to Staff comments do not foreclose the Securities and Exchange
Commission from taking any action with respect to such filings, and (iii)&nbsp;the Company may not assert Staff comments as a defense in any proceeding initiated by the Securities and Exchange
Commission or any person under the federal securities laws of the United States.

<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt; display: none">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="left" style="font-size: 10pt; text-indent: 4%">If you have any questions regarding the responses to your questions, please feel free to contact me at
973-535-2717 or Stephen Zelnick of Morse, Zelnick, Rose and Lander, LLP, our securities counsel, at 212-838-8040.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="60%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD colspan="3">Respectfully submitted,</TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD>&nbsp;</TD>
    <TD colspan="3">&nbsp;</TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD>&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000">/s/&nbsp;Joseph D&#146;Agostino</TD>
</TR>
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD colspan="3" align="left" valign="top">Joseph D&#146;Agostino<BR>
Chief Financial Officer</TD>
</TR>
</TABLE>
</DIV>


<P align="left" style="font-size: 10pt">cc: Stephen Zelnick

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">6

</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
